(Q38140035)

29 August 2017

title

Challenges in reducing dengue burden; diagnostics, control measures and vaccines (English)

1 reference

29 August 2017

0 references

Sai Kit Lam

1

1 reference

29 August 2017

publication date

1 September 2013

1 reference

Expert Review of Vaccines

29 August 2017

published in

1 reference

29 August 2017

volume

12

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

995-1010

1 reference

Update on the global spread of dengue

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Economic impact of dengue illness in the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Cost-effectiveness of a pediatric dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue: a continuing global threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Review of dengue virus and the development of a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Continuing challenge of infectious diseases in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Recent shift in age pattern of dengue hemorrhagic fever, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Inappropriate use of emergency services: a systematic review of prevalence and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Recent introduction and rapid dissemination of Chikungunya virus and Dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Race: a risk factor for dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The dengue situation in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The global distribution and burden of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The growing burden of dengue in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Spectrum of disease and relation to place of exposure among ill returned travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The burden of dengue infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The health and economic impact of dengue in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The WHO dengue classification and case definitions: time for a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Poverty, user fees and ability to pay for health care for children with suspected dengue in rural Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Out-of-pocket health expenditure and debt in poor households: evidence from Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Aedes albopictus and the reemergence of Dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Immune response to dengue virus and prospects for a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue and other emerging flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Pathogenesis of dengue: challenges to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Human skin Langerhans cells are targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The mannose receptor mediates dengue virus infection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

21 January 2018

Dengue virus receptor

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Antibody-enhanced dengue virus infection in primate leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The pathogenesis of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

A three-component biomarker panel for prediction of dengue hemorrhagic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Cytokine expression profile of dengue patients at different phases of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Controversies in dengue pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The revised WHO dengue case classification: does the system need to be modified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

First Outbreak of Dengue Hemorrhagic Fever, Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Severe dengue: the need for new case definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Evaluation of the traditional and revised WHO classifications of Dengue disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Evaluation of diagnostic tests: dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Association of platelet count and serological markers of dengue infection- importance of NS1 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Evaluation of a novel commercial rapid test for dengue diagnosis based on specific IgA detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Community involvement in dengue vector control: cluster randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue prevention and 35 years of vector control in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue vector control strategies in an urban setting: an economic modelling assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Levels of insecticide resistance and resistance mechanisms in Aedes aegypti from some Latin American countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Sustainability and cost of a community-based strategy against Aedes aegypti in northern and central Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Rapid spread of an inherited incompatibility factor in California Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Female-specific flightless phenotype for mosquito control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Genetic elimination of dengue vector mosquitoes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Biosafety concerns involving genetically modified mosquitoes to combat malaria and dengue in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Development of dengue DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Progress towards a dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

The necessity and quandaries of dengue vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Dengue vaccine prospects: a step forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Mouse models of dengue virus infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Unique challenges faced by the clinical evaluation of dengue vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Rotavirus vaccine introduction in the Americas: progress and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Estimating potential demand and supply of dengue vaccine in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

Call for a World Dengue Day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824712

10.1586/14760584.2013.824712

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference